Cargando…

Pain Detection with Bioimpedance Methodology from 3-Dimensional Exploration of Nociception in a Postoperative Observational Trial

Although the measurement of dielectric properties of the skin is a long-known tool for assessing the changes caused by nociception, the frequency modulated response has not been considered yet. However, for a rigorous characterization of the biological tissue during noxious stimulation, the bioimped...

Descripción completa

Detalles Bibliográficos
Autores principales: Neckebroek, Martine, Ghita, Mihaela, Ghita, Maria, Copot, Dana, Ionescu, Clara M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141233/
https://www.ncbi.nlm.nih.gov/pubmed/32143327
http://dx.doi.org/10.3390/jcm9030684
_version_ 1783519152222240768
author Neckebroek, Martine
Ghita, Mihaela
Ghita, Maria
Copot, Dana
Ionescu, Clara M.
author_facet Neckebroek, Martine
Ghita, Mihaela
Ghita, Maria
Copot, Dana
Ionescu, Clara M.
author_sort Neckebroek, Martine
collection PubMed
description Although the measurement of dielectric properties of the skin is a long-known tool for assessing the changes caused by nociception, the frequency modulated response has not been considered yet. However, for a rigorous characterization of the biological tissue during noxious stimulation, the bioimpedance needs to be analyzed over time as well as over frequency. The 3-dimensional analysis of nociception, including bioimpedance, time, and frequency changes, is provided by ANSPEC-PRO device. The objective of this observational trial is the validation of the new pain monitor, named as ANSPEC-PRO. After ethics committee approval and informed consent, 26 patients were monitored during the postoperative recovery period: 13 patients with the in-house developed prototype ANSPEC-PRO and 13 with the commercial device MEDSTORM. At every 7 min, the pain intensity was measured using the index of Anspec-pro or Medstorm and the 0–10 numeric rating scale (NRS), pre-surgery for 14 min and post-anesthesia for 140 min. Non-significant differences were reported for specificity-sensitivity analysis between ANSPEC-PRO (AUC = 0.49) and MEDSTORM (AUC = 0.52) measured indexes. A statistically significant positive linear relationship was observed between Anspec-pro index and NRS (r(2) = 0.15, p < 0.01). Hence, we have obtained a validation of the prototype Anspec-pro which performs equally well as the commercial device under similar conditions.
format Online
Article
Text
id pubmed-7141233
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71412332020-04-10 Pain Detection with Bioimpedance Methodology from 3-Dimensional Exploration of Nociception in a Postoperative Observational Trial Neckebroek, Martine Ghita, Mihaela Ghita, Maria Copot, Dana Ionescu, Clara M. J Clin Med Article Although the measurement of dielectric properties of the skin is a long-known tool for assessing the changes caused by nociception, the frequency modulated response has not been considered yet. However, for a rigorous characterization of the biological tissue during noxious stimulation, the bioimpedance needs to be analyzed over time as well as over frequency. The 3-dimensional analysis of nociception, including bioimpedance, time, and frequency changes, is provided by ANSPEC-PRO device. The objective of this observational trial is the validation of the new pain monitor, named as ANSPEC-PRO. After ethics committee approval and informed consent, 26 patients were monitored during the postoperative recovery period: 13 patients with the in-house developed prototype ANSPEC-PRO and 13 with the commercial device MEDSTORM. At every 7 min, the pain intensity was measured using the index of Anspec-pro or Medstorm and the 0–10 numeric rating scale (NRS), pre-surgery for 14 min and post-anesthesia for 140 min. Non-significant differences were reported for specificity-sensitivity analysis between ANSPEC-PRO (AUC = 0.49) and MEDSTORM (AUC = 0.52) measured indexes. A statistically significant positive linear relationship was observed between Anspec-pro index and NRS (r(2) = 0.15, p < 0.01). Hence, we have obtained a validation of the prototype Anspec-pro which performs equally well as the commercial device under similar conditions. MDPI 2020-03-04 /pmc/articles/PMC7141233/ /pubmed/32143327 http://dx.doi.org/10.3390/jcm9030684 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Neckebroek, Martine
Ghita, Mihaela
Ghita, Maria
Copot, Dana
Ionescu, Clara M.
Pain Detection with Bioimpedance Methodology from 3-Dimensional Exploration of Nociception in a Postoperative Observational Trial
title Pain Detection with Bioimpedance Methodology from 3-Dimensional Exploration of Nociception in a Postoperative Observational Trial
title_full Pain Detection with Bioimpedance Methodology from 3-Dimensional Exploration of Nociception in a Postoperative Observational Trial
title_fullStr Pain Detection with Bioimpedance Methodology from 3-Dimensional Exploration of Nociception in a Postoperative Observational Trial
title_full_unstemmed Pain Detection with Bioimpedance Methodology from 3-Dimensional Exploration of Nociception in a Postoperative Observational Trial
title_short Pain Detection with Bioimpedance Methodology from 3-Dimensional Exploration of Nociception in a Postoperative Observational Trial
title_sort pain detection with bioimpedance methodology from 3-dimensional exploration of nociception in a postoperative observational trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141233/
https://www.ncbi.nlm.nih.gov/pubmed/32143327
http://dx.doi.org/10.3390/jcm9030684
work_keys_str_mv AT neckebroekmartine paindetectionwithbioimpedancemethodologyfrom3dimensionalexplorationofnociceptioninapostoperativeobservationaltrial
AT ghitamihaela paindetectionwithbioimpedancemethodologyfrom3dimensionalexplorationofnociceptioninapostoperativeobservationaltrial
AT ghitamaria paindetectionwithbioimpedancemethodologyfrom3dimensionalexplorationofnociceptioninapostoperativeobservationaltrial
AT copotdana paindetectionwithbioimpedancemethodologyfrom3dimensionalexplorationofnociceptioninapostoperativeobservationaltrial
AT ionescuclaram paindetectionwithbioimpedancemethodologyfrom3dimensionalexplorationofnociceptioninapostoperativeobservationaltrial